We are live on
!
Find out more
PVLA
Palvella Therapeutics
PVLA
PVLA
18 hedge funds and large institutions have $40.5M invested in Palvella Therapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
38% more funds holding
Funds holding: 13 → 18 (+5)
20% more capital invested
Capital invested by funds: $33.8M → $40.5M (+$6.69M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
3
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$334K |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$239K |
| 3 |
SIM
Spark Investment Management
New York
|
+$63.5K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$31.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$26.4K |